Robert Harding

Exclusive only  
Color search  
Orientation
Release
License
People
Age Group
Ethnicity
Image size
more filters

Recent searches

Loading...
1348-5370 - Ebola virus particles (blue) found both as extracellular particles and budding particles from chronically infected African green monkey kidney cells. Image captured and color-enhanced at the NIAID Integrated Research Facility in Ft. Detrick, Maryland.
1348-3930 - Clinical research in the GHICL. The physical medicine and rehabilitation department in Saint Philibert hospital in Lille, France. Exercises to develop the patient's muscle tone in functional rehabilitation, under the supervision of a doctor and medico-sporting educator.
1348-2524 - Rome, Reithera, a company specialized in biotechnology, based on the outskirts of Rome, is working on the anti-Covid vaccine GRAd-CoV2, which represents the Italian response to Pfizer and Moderna vaccines. After phase 1 of the testing, the Reithera vaccine proved to be safe and capable of inducing an immune response, as confirmed by the scientific director of the Lazzaro Spallanzani Hospital in Rome. In the photo the researchers at work in the laboratories
1348-3459 - Reportage at the Neuroimaging research centre in Pitie Salpetriere hospital in Paris, France. Magnetoencephalography (MEG) platform. MEG detects variations in the brain's magnetic field during various types of cerebral activity. It studies normal and abnormal brain function. Recording the magnetic field produced by neuronal currents requires ultra sensitive sensors called SQUIDs (Superconducting Quantum Interference Device). The 306 sensors spread over 102 areas allow both near and far magnetic fields to be measured, and the brain's deep structures to be 'seen'.
1348-3929 - Clinical research in the GHICL. The physical medicine and rehabilitation department in Saint Philibert hospital in Lille, France. Exercises to develop the patient's muscle tone in functional rehabilitation, under the supervision of a doctor and medico-sporting educator.
1348-2523 - Rome, Reithera, a company specialized in biotechnology, based on the outskirts of Rome, is working on the anti-Covid vaccine GRAd-CoV2, which represents the Italian response to Pfizer and Moderna vaccines. After phase 1 of the testing, the Reithera vaccine proved to be safe and capable of inducing an immune response, as confirmed by the scientific director of the Lazzaro Spallanzani Hospital in Rome. In the photo the researchers at work in the laboratories
1348-3928 - Clinical research in the GHICL. The physical medicine and rehabilitation department in Saint Philibert hospital in Lille, France. Exercises to develop the patient's muscle tone in functional rehabilitation, under the supervision of a doctor.
1348-2525 - Rome, Reithera, a company specialized in biotechnology, based on the outskirts of Rome, is working on the anti-Covid vaccine GRAd-CoV2, which represents the Italian response to Pfizer and Moderna vaccines. After phase 1 of the testing, the Reithera vaccine proved to be safe and capable of inducing an immune response, as confirmed by the scientific director of the Lazzaro Spallanzani Hospital in Rome. In the photo Antonella Folgori, Chief Executive Officer and Chairman of the Board of Directors - REITHERA
1348-3456 - Reportage at the Neuroimaging research centre in Pitie Salpetriere hospital in Paris, France. Magnetoencephalography (MEG) platform. MEG detects variations in the brain's magnetic field during various types of cerebral activity. It studies normal and abnormal brain function. Recording the magnetic field produced by neuronal currents requires ultra sensitive sensors called SQUIDs (Superconducting Quantum Interference Device). The 306 sensors spread over 102 areas allow both near and far magnetic fields to be measured, and the brain's deep structures to be 'seen'.